Literature DB >> 21301223

Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008.

Fabiola Micheletti1, Ugo Moretti, Giuseppe Tridente, Giovanna Zanoni.   

Abstract

Prevention and control of adverse events following immunization (AEFI) are fundamental activities of successful immunisation programs. AEFI reporting, investigation and analysis, integrated by consultancy for subjects needing a specialized evaluation, represent an ideal model for vaccine safety surveillance. In the Veneto Region of Italy the Green Channel Centre has been created by the local Public Health authority, to offer a consultancy activity for vaccinations at risk of adverse events and to ensure an efficient AEFI surveillance system with regular feedback data for vaccine personnel. This report updates the overall activity provided by the Green Channel between 1992 and 2008, concerning consultations for previous AEFI and contraindications to vaccinations and analysis of AEFI reports. After 1280 consultancy cases, 998 (78%) subjects were found eligible for vaccination, with personalized precautions suggested in 42% of cases. Of a total of 724 patients actually vaccinated as per the Green Channel instructions, only 55 subjects (7.6%) reported mild symptoms and one (0.3%) a moderate allergic reaction. Since 1993, a total of 5,006 AEFI reports have been collected and evaluated by the Green Channel against more than 20 millions of vaccine doses administered with an estimate mean AEFI rate of 2.3 x 10.000 doses per year. The majority of them (94%) were found in causal relationship with vaccines; of these, 267 reports (5,6% - 0.1/10,000 doses) were serious and 9 of these subjects, affected by a neurological event, were not recovered or were still on therapy at follow up. This regional activity has proven efficacious in evaluating and managing individual cases at potential risk of AEFI and integrating the national passive surveillance system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301223     DOI: 10.4161/hv.7.0.14613

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  6 in total

1.  A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy.

Authors:  Silvia Cocchio; Giovanna Zanoni; Roberta Opri; Francesca Russo; Vincenzo Baldo
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.

Authors:  Cristiano Alicino; Caterina Merlano; Simona Zappettini; Sergio Schiaffino; Giovanni Della Luna; Cristina Accardo; Roberto Gasparini; Paolo Durando; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 3.  Best vaccination practice and medically attended injection site events following deltoid intramuscular injection.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

Review 5.  Sepsis, parenteral vaccination and skin disinfection.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

6.  Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017.

Authors:  F Moretti; L Gonella; S Gironi; A R Marra; C Santuccio; P Felicetti; F Petronzelli; P Marchione; S A Barnaba; A Poli; G Zanoni; U Moretti
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.